论文部分内容阅读
油酸单乙醇胺(monoethanolamine oleate,Oldamin)于1996年6月获准在日本上市,其适应证为:“食道静脉曲张出血和肝硬化”。 鉴于该药与胃肠道疾病有关,禁忌证内容中增加了由于胃/十二指肠溃疡或胃糜烂引起出血的患者;“其他不良反应”部分增加了出血性胃炎和由
Monoethanolamine oleate (monoethanolamine oleate) was approved for marketing in Japan in June 1996 as indications of “esophageal variceal bleeding and cirrhosis.” In view of the drug is associated with gastrointestinal diseases, contraindications increased in patients with bleeding due to stomach / duodenal ulcer or gastric erosion; “Other adverse reactions” part of the increased hemorrhagic gastritis and by